Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Current Deferred Revenue (2016)

Microbot Medical's Current Deferred Revenue history spans 7 years, with the latest figure at $16826.0 for Q3 2016.

  • For the quarter ending Q3 2016, Current Deferred Revenue changed 0.0% year-over-year to $16826.0, compared with a TTM value of $16826.0 through Sep 2016, changed 0.0%, and an annual FY2015 reading of $132338.0, changed N/A over the prior year.
  • Current Deferred Revenue for Q3 2016 was $16826.0 at Microbot Medical, roughly flat from $16826.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $141344.0 in Q1 2016, with the low at $1627.0 in Q1 2012.
  • Average Current Deferred Revenue over 5 years is $53237.9, with a median of $47231.0 recorded in 2014.
  • Year-over-year, Current Deferred Revenue surged 2886.79% in 2013 and then plummeted 62.41% in 2015.
  • Tracing MBOT's Current Deferred Revenue over 5 years: stood at $74426.0 in 2012, then decreased by 9.65% to $67245.0 in 2013, then increased by 27.78% to $85925.0 in 2014, then soared by 54.02% to $132338.0 in 2015, then tumbled by 87.29% to $16826.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Current Deferred Revenue are $16826.0 (Q3 2016), $16826.0 (Q2 2016), and $141344.0 (Q1 2016).